2. Alpsoy E. Behçet’s disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43(6):620-32. DOI: 10.1111/1346-8138. Epub 2016 Apr 14.2707594210.1111/1346-8138.Epub2016Apr14
3. Koné-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, et al. Familial aggregation in Behçet’s disease: high frequency in siblings and parents of pediatric probands. J Pediatr. 1999;135(1):89-93.10.1016/S0022-3476(99)70333-1
4. de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Behçet’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009; 61(10):1287-96. DOI: 10.1002/art.24642.10.1002/art.24642
5. Veyseller B, Dogan R, Ozücer B, Aksoy F, Meric A, Su O, et al. Olfactory function and nasal manifestations of Behçet’s disease. Auris Nasus Larynx. 2014;41(2):185-9. DOI: 10.1016/j.anl.2013.07.014. Epub 2013 Oct 30.2418339710.1016/j.anl.2013.07.014.Epub2013Oct30
6. Ozbay I, Kucur C, Temizturk F, Ozkan Y, Kahraman C, Oghan F. Assessment of nasal mucociliary activity in patients with Behçet’s disease. J Laryngol Otol. 2016;130(4):348-51. DOI: 10.1017/S0022215116000207. Epub 2016 Feb 4.10.1017/S0022215116000207.Epub2016Feb4
7. Krause I, Yankevich A, Fraser A, Rosner I, Mader R, Zisman D, et al. Prevalence and clinical aspects of Behcet’s disease in the north of Israel. Clin Rheumatol. 2007;26(4):555-60. Epub 2006 Aug 1.10.1007/s10067-006-0349-4
8. Sakane T, Suzuki N, Takeno M. Innate and acquired immunity in Behçet’s disease. 8th International Congress on Behçet’s Disease. Reggio Emilia, Italy, 7-9 October 1998. Program and Abstracts: 56.
10. Direskeneli H, Eksioglu-Demiralp E, Yavuz S, Ergun T, Shinnick T, Lehner T, et al. T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet’s disease. J Rheumatol. 2000;27(3):708-13.
11. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behçet’s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum. 1999;42(9):1967-74.10.1002/1529-0131(199909)42:9<;1967::AID-ANR24>3.0.CO;2-Z
12. Sugi-Ikai N, Nakazawa M, Nakamura S, Ohno S, Minami M. Increased frequencies of interleukin-2-and interferon-gamma-producing T cells in patients with active Behçet’s disease. Invest Ophthalmol Vis Sci. 1998;39(6):996-1004.
14. Dhong HJ, Kim HY, Ha BS. Histologic changes to olfactory epithelium in hypothyroid rats. Otolaryngol Head Neck Surg. 2003;129(1):24–32.10.1016/S0194-5998(03)00530-8
16. Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope. 2000;110(7):1071–7.10.1097/00005537-200007000-00001
17. Callahan CD, Hinkebein JH. Assessment of anosmia after traumatic brain injury: performance characteristics of the University of Pennsylvania Smell Identification Test. J Head Trauma Rehabil. 2002;17(3):251–6.10.1097/00001199-200206000-00006
19. Klimek L, Moll B, Amedee RG, Mann WJ. Olfactory function after microscopic endonasal surgery in patients with nasal polyps. Am J Rhinol. 1997;11(4):251-5.10.2500/105065897781446621
20. Landis BN, Scheibe M, Weber C, Berger R, Bramerson A, Bende M, et al. Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol. 2010;257(8):1303-8. DOI: 10.1007/s00415-010-5513-8. Epub 2010 Mar 11.10.1007/s00415-010-5513-8
23. Ortega-Hernandez OD, Kivity S, Shoenfeld Y. Olfaction, psychiatric disorders and autoimmunity: is there a common genetic association? Autoimmunity. 2009;42(1):80-8. DOI: 10.1080/08916930802366140.10.1080/0891693080236614019127459
24. Shoenfeld N, Agmon-Levin N, Flitman-Katzevman I, Paran D, Katz BS, Kivity S, et al. The sense of smell in systemic lupus erythematosus. Arthritis Rheum. 2009;60(5):1484-7. DOI: 10.1002/art.24491.10.1002/art.2449119404932
25. O’Devaney K, Ferlito A, Devaney SL, Huner BC, Rinaldo A. Wegener’s granulomatosis of the head and neck. Ann Otol Rhinol Laryngol. 1996;107:439-45. DOI: 10.1177/000348949810700515.10.1177/0003489498107005159596226
26. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrouse B, Casassus P. Churg–Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999;78(1):26-37.10.1097/00005792-199901000-000039990352
28. Rasmussen N, Brofeldt S, Manthorpe R. Smell and nasal findings in patients with primary Sjögren’s syndrome. Scand J Rheumatol Suppl. 1986;61:142-5.
29. Weisman RA, Calcaterra TC. Head and neck manifestations of scleroderma. Ann Otol Rhinol Laryngol. 1978;87(3 Pt 1):332-9.10.1177/000348947808700307655570
34. Siva A, Altintas A, Saip S. Behcet’s syndrome and the nervous system. Curr Opin Neurol. 2004;17(3):347-57.1516707110.1097/00019052-200406000-0001715167071
37. Shahram F, Zarandy MM, Ibrahim A, Ziaie N, Saidi M, Nabaei B, et al. Nasal mucosal involvement in Behcet disease: a study of its incidence and characteristics in 400 patients. Ear Nose Throat J. 2010;89(1):30-3.10.1177/014556131008900109
39. Meric A, Dogan R, Su O, Eren SB, Tugrul S, Ozturan O. Correlation of Otorhinolaryngologic Symptoms with Physical Findings in Behçet’s Disease. B-ENT. 2015;11(1):31-7.
41. Verim A, Cebeci F, Baser E, Calim ÖF, Kadioğlu D, Kocagöz GD. Prevalence of chronic rhinosinusitis in the setting of Behçet disease. J Craniofac Surg. 2015;26(1):186-90. DOI: 10.1097/SCS.0000000000001202.10.1097/SCS.000000000000120225469896
42. Direskeneli H. Autoimmunity vs autoinflammation in Behcet’s disease: do we oversimplify a complex disorder? Rheumatology. 2006;45(12):1461-5. Epub 2006 Sep 23.10.1093/rheumatology/kel32916998234
43. Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003;4(7):441-7.10.2165/00128071-200304070-0000112814334